AR089518A1 - Costra artificial porosa semipermeable - Google Patents
Costra artificial porosa semipermeableInfo
- Publication number
- AR089518A1 AR089518A1 ARP120105043A ARP120105043A AR089518A1 AR 089518 A1 AR089518 A1 AR 089518A1 AR P120105043 A ARP120105043 A AR P120105043A AR P120105043 A ARP120105043 A AR P120105043A AR 089518 A1 AR089518 A1 AR 089518A1
- Authority
- AR
- Argentina
- Prior art keywords
- crust
- semipermeable
- costra
- damaged
- portable artificial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0085—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
- A61L2300/222—Steroids, e.g. corticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/442—Colorants, dyes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Prostheses (AREA)
Abstract
Costra artificial porosa semipermeable autofijable diseñada para la protección de superficies erosionadas o lesionadas. Es aplicable sobre todo ser vivo. (Incluyendo vegetales) La trama polimerizada de la costra se forma al aplicarse sobre la superficie dañada por reacción catalizada por la acción de las enzimas liberadas por las células lisadas. Bajo esta superficie protectora se favorece el crecimiento de nuevas células normales que pueden respirar libremente sin desecarse. Evita perdida de agua, proteínas y electrolitos, protege de infecciones y reemplaza el uso de gasas o apósitos que lesionan la piel nueva al retirarse. La mezcla acuosa de color rojo aplicada por pincelación o atomización de características tixotropicas fue obtenida por la interacción fisicoquímica en el envase de los siguientes compuestos: azosulfamida entre 1 y 5 g% + violeta de genciana entre 0,004 y 0,007 g% + dexametasona, entre 0,001 y 0,003 g% + pantenol entre 0,5 y 2 g% + gentamicina 0,03 y 0,06 g%.
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP120105043A AR089518A1 (es) | 2012-12-27 | 2012-12-27 | Costra artificial porosa semipermeable |
UY0001035111A UY35111A (es) | 2012-12-27 | 2013-11-01 | Costra artificial porosa semipermeable |
CN201380068529.0A CN105073121B (zh) | 2012-12-27 | 2013-11-04 | 半透性多孔人造痂的形成 |
BR112015014785-2A BR112015014785B1 (pt) | 2012-12-27 | 2013-11-04 | Composição para a formação de cobertura artificial porosa |
AU2013368699A AU2013368699B2 (en) | 2012-12-27 | 2013-11-04 | Formation of semi-permeable porous artificial scab |
EP13867652.3A EP2939678B1 (en) | 2012-12-27 | 2013-11-04 | Thixotropic fluid for use as a cicatrizing agent |
US14/655,677 US20160000963A1 (en) | 2012-12-27 | 2013-11-04 | Formation of semi-permeable porous artifical scab |
MX2015007747A MX2015007747A (es) | 2012-12-27 | 2013-11-04 | Formacion de costra artificial porosa semipermeable. |
ES13867652.3T ES2633970T3 (es) | 2012-12-27 | 2013-11-04 | Fluido tixotrópico para uso como agente cicatrizante |
PE2015000904A PE20160748A1 (es) | 2012-12-27 | 2013-11-04 | Formacion de costra artificial porosa semipermeable |
JP2015550354A JP6073500B2 (ja) | 2012-12-27 | 2013-11-04 | 半透多孔性の人工かさぶたの形成 |
RU2015128753A RU2015128753A (ru) | 2012-12-27 | 2013-11-04 | Формирование полупроницаемого пористого искусственного струпа |
CA2896488A CA2896488C (en) | 2012-12-27 | 2013-11-04 | Formation of semi-permeable porous artificial scab |
PCT/PE2013/000010 WO2014104898A2 (es) | 2012-12-27 | 2013-11-04 | Formación de costra artificial porosa semipermeable |
IL239618A IL239618B (en) | 2012-12-27 | 2015-06-24 | A thixothermic liquid for use as an exfoliating agent |
US16/115,874 US20190022274A1 (en) | 2012-12-27 | 2018-08-29 | Formation of semi-permeable porous artificial scab |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP120105043A AR089518A1 (es) | 2012-12-27 | 2012-12-27 | Costra artificial porosa semipermeable |
Publications (1)
Publication Number | Publication Date |
---|---|
AR089518A1 true AR089518A1 (es) | 2014-08-27 |
Family
ID=49959135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120105043A AR089518A1 (es) | 2012-12-27 | 2012-12-27 | Costra artificial porosa semipermeable |
Country Status (15)
Country | Link |
---|---|
US (2) | US20160000963A1 (es) |
EP (1) | EP2939678B1 (es) |
JP (1) | JP6073500B2 (es) |
CN (1) | CN105073121B (es) |
AR (1) | AR089518A1 (es) |
AU (1) | AU2013368699B2 (es) |
BR (1) | BR112015014785B1 (es) |
CA (1) | CA2896488C (es) |
ES (1) | ES2633970T3 (es) |
IL (1) | IL239618B (es) |
MX (1) | MX2015007747A (es) |
PE (1) | PE20160748A1 (es) |
RU (1) | RU2015128753A (es) |
UY (1) | UY35111A (es) |
WO (1) | WO2014104898A2 (es) |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2364563A (en) * | 1941-09-25 | 1944-12-05 | John B Stribling | Keratitic medicament |
US3146162A (en) * | 1961-05-05 | 1964-08-25 | Harold A Abramson | Gentian violet adsorption complex |
US3238100A (en) * | 1963-07-23 | 1966-03-01 | American Maize Prod Co | Starch phosphate film composition and method of dressing wounds with same |
US3328259A (en) * | 1964-01-08 | 1967-06-27 | Parachem Corp | Dressing for a wound containing a hemostatic agent and method of treating a wound |
US3577516A (en) * | 1969-12-02 | 1971-05-04 | Nat Patent Dev Corp | Preparation of spray on bandage |
US3969498A (en) * | 1973-09-13 | 1976-07-13 | University Of The Pacific | Dressing and method for treating a wound |
JP3261807B2 (ja) * | 1992-06-09 | 2002-03-04 | 味の素株式会社 | チキソトロピーを有するゲル状組成物 |
US20040018241A1 (en) * | 1997-09-26 | 2004-01-29 | Noven Pharmaceuticals, Inc. | Bioadhesive compositions and methods for topical administration of active agents |
FR2819721B1 (fr) * | 2001-01-19 | 2005-02-04 | L M D | Traitement des escarres avec sucre non metabolisable et un absorbant polymerique |
WO2003043548A1 (en) * | 2001-11-20 | 2003-05-30 | Visco Dye Aps | Visco dye |
US20030203032A1 (en) * | 2002-04-25 | 2003-10-30 | Schultz Clyde L. | Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
ATE476218T1 (de) * | 2002-08-20 | 2010-08-15 | Gen Wound Kare Inc A Corp Of D | Verfahren zur herstellung eines medizinischen polsters |
DE10357046A1 (de) * | 2003-12-04 | 2005-06-30 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen enthaltend eine Kombination aus grünem Farbstoff und antiinflammatorischem Wirkstoff |
CN1293883C (zh) * | 2004-05-21 | 2007-01-10 | 邹宏 | 一种美容修护液及其制备方法 |
US20070161936A1 (en) * | 2006-01-06 | 2007-07-12 | Svetlik Harvey E | Wound treatment-dressing and method of manufacture |
ES2304103B1 (es) * | 2007-02-22 | 2009-08-07 | Biocosmetics S.L. | Composicion para tratamiento de la xerostomia o boca seca. |
CN103037858A (zh) * | 2010-07-02 | 2013-04-10 | 华柏恩视觉研究中心 | 用于预防和治疗接触镜致乳头性结膜炎以及过敏性眼病的组合物 |
CN101947226A (zh) * | 2010-09-10 | 2011-01-19 | 李晓倩 | 治疗红眼病的滴液 |
-
2012
- 2012-12-27 AR ARP120105043A patent/AR089518A1/es active IP Right Grant
-
2013
- 2013-11-01 UY UY0001035111A patent/UY35111A/es not_active Application Discontinuation
- 2013-11-04 CN CN201380068529.0A patent/CN105073121B/zh not_active Expired - Fee Related
- 2013-11-04 BR BR112015014785-2A patent/BR112015014785B1/pt not_active IP Right Cessation
- 2013-11-04 PE PE2015000904A patent/PE20160748A1/es not_active Application Discontinuation
- 2013-11-04 US US14/655,677 patent/US20160000963A1/en not_active Abandoned
- 2013-11-04 CA CA2896488A patent/CA2896488C/en not_active Expired - Fee Related
- 2013-11-04 JP JP2015550354A patent/JP6073500B2/ja not_active Expired - Fee Related
- 2013-11-04 AU AU2013368699A patent/AU2013368699B2/en not_active Ceased
- 2013-11-04 EP EP13867652.3A patent/EP2939678B1/en not_active Not-in-force
- 2013-11-04 RU RU2015128753A patent/RU2015128753A/ru not_active Application Discontinuation
- 2013-11-04 ES ES13867652.3T patent/ES2633970T3/es active Active
- 2013-11-04 MX MX2015007747A patent/MX2015007747A/es unknown
- 2013-11-04 WO PCT/PE2013/000010 patent/WO2014104898A2/es active Application Filing
-
2015
- 2015-06-24 IL IL239618A patent/IL239618B/en active IP Right Grant
-
2018
- 2018-08-29 US US16/115,874 patent/US20190022274A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20190022274A1 (en) | 2019-01-24 |
EP2939678B1 (en) | 2017-04-19 |
IL239618A0 (en) | 2015-08-31 |
MX2015007747A (es) | 2015-09-04 |
CA2896488A1 (en) | 2014-07-03 |
PE20160748A1 (es) | 2016-08-21 |
JP2016504357A (ja) | 2016-02-12 |
JP6073500B2 (ja) | 2017-02-01 |
IL239618B (en) | 2018-01-31 |
BR112015014785B1 (pt) | 2021-11-30 |
AU2013368699B2 (en) | 2017-08-10 |
CA2896488C (en) | 2017-11-21 |
AU2013368699A1 (en) | 2015-07-16 |
CN105073121B (zh) | 2018-12-04 |
EP2939678A4 (en) | 2016-06-08 |
BR112015014785A2 (pt) | 2017-08-15 |
US20160000963A1 (en) | 2016-01-07 |
UY35111A (es) | 2013-12-31 |
WO2014104898A2 (es) | 2014-07-03 |
EP2939678A2 (en) | 2015-11-04 |
CN105073121A (zh) | 2015-11-18 |
ES2633970T3 (es) | 2017-09-26 |
WO2014104898A3 (es) | 2015-01-08 |
RU2015128753A (ru) | 2017-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP12012353A (es) | Compuestos, composiciones de tioacetato y métodos de uso | |
NI201800026A (es) | Derivados de triazol, sus intermediarios y su utilización como fungicida | |
WO2017163132A3 (en) | Use of umbilical cord blood derived exosomes for tissue repair | |
CL2017002727A1 (es) | Composiciones de ácido obeticólico y métodos de uso | |
AR084378A1 (es) | Combinaciones de compuestos activos | |
CL2010001382A1 (es) | Compuestos derivados de acido 1-heteroaril-pirazol -4 il acetico; su procedimiento de preparacion; agente herbicida que los contiene; procedimiento para la represion de plantas daninas; y uso de dichos compuestos para preparar composiciones herbicidas o reguladoras del crecimiento de las plantas. | |
CR11731A (es) | Composiciones y procedimientos para su preparación y uso | |
CL2008002537A1 (es) | Compuestos derivados de acido 6-fenil-nicotinico, con actividad moduladora de ppar-alfa; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso para tratar y/o prevenir dislipidemias, arteriosclerosis e insuficiencia cardiaca. | |
UY35426A (es) | Compuestos y sus usos en la modulación de la hemoglobina | |
ECSP18012793A (es) | Composición y productos que comprenden células senescentes para su uso en la regeneración de tejidos | |
CL2014000630A1 (es) | Una composicion que comprende 1) un compuesto derivado de nucleosido denominado como compuesto 10 y 2) un compuesto derivado de acido 5-tiofeno-2-carboxilico denominado como compuesto 5 o un compuesto derivado del ester metilico del acido carbamico denominado como compuesto 6; y su uso para el tratamiento profilactico o terapeutico de una infeccion por vhc. | |
BR112012018839A2 (pt) | "composição v´trea seca compreendendo um material bioativo" | |
AR084567A1 (es) | Implante con calcio en su superficie y metodos de modificacion de la superficie de un implante para dotar a dicha superficie de calcio | |
CL2013002517A1 (es) | Compuestos derivados de fosforoamidato de 5-fluoro-2'-desoxiuridina; procedimiento de preparacion; composicion farmaceutica que los comprende; su uso en el tratamiento o profilaxis del cancer. | |
ECSP13012482A (es) | Derivados de 5-yodo-triazol | |
CL2013002933A1 (es) | Composicion inmunogenica de reovirus de peces (prv) que comprende acido nucleico del prv; polipeptido; uso de la composicion inmunogenica que sirve para tratar afecciones de infeccion por prv en un animal | |
BR112018003031A2 (pt) | formulações clínicas | |
PE20151426A1 (es) | Solucion para preservar conductos vasculares | |
BR112012032193A2 (pt) | composto, composiçoes e métodos de uso de feniltioacetato | |
UY34491A (es) | La composición herbicida que contiene ácido de 4-amino-3-cloro-6- (4-cloro-2-flúor-3-metoxifenil) pyridina-2-carboxílico o los derivados de los mismos y fluroxipir o los derivados de los mismos | |
BRPI0902603A8 (pt) | uso cosmético de pelo menos um composto ditiolano, composto ditiolano, composição e processo cosmético de preparação da pele para o sol | |
CL2012002019A1 (es) | Combinaciones de principios activos acaricidas y/o insecticidas; uso de dichas combinaciones para combatir plagas animales del orden de los ácaros. | |
CL2015003016A1 (es) | Derivados de triazol novedosos | |
EA201201239A1 (ru) | Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением | |
WO2019112161A3 (ko) | 조류의 에그로부터 분리한 세포인 배반엽 전분화능세포, 신경줄기세포, 배아섬유아세포 컨디션드 배지를 유효성분으로 하는 세포 증식, 피부재생 및 주름 개선용 배지 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |